Hepatitis C infection and chronic renal diseases

Aline Gonzalez Vigani1,2

  • 1Departamento de Clínica Médica da Disciplina de Moléstias Infecciosas, Grupo de Estudo das Hepatites Virais, Universidade Estadual de Campinas (Unicamp), Campinas, Brazil. aline.vigani@sigmanet.com.br.

Insights

Hepatitis C virus (HCV) infection can cause kidney disease, and end-stage renal disease patients are more likely to get HCV. Management guidelines are lacking due to limited research.

Area of Science:

  • Nephrology
  • Hepatology
  • Infectious Diseases

Background:

  • Hepatitis C virus (HCV) infection and chronic renal diseases share a complex bidirectional relationship.
  • HCV can precipitate certain renal diseases, while end-stage renal disease (ESRD) patients face heightened risk of HCV acquisition.
  • Co-occurrence of chronic HCV and renal disease is associated with poor patient prognosis.

Purpose of the Study:

  • To review current insights into Hepatitis C virus infection as an extrahepatic manifestation.
  • To explore HCV infection as a complication in patients with end-stage renal disease.
  • To highlight the need for evidence-based management strategies for this dual condition.

Main Methods:

  • Review of existing literature on HCV infection and renal diseases.
  • Analysis of studies focusing on HCV as an extrahepatic manifestation.
  • Examination of research concerning HCV in end-stage renal disease patients.

Main Results:

  • Limited uncontrolled trials with small sample sizes characterize current research.
  • A significant lack of evidence-based recommendations and clinical guidelines exists.
  • The interplay between HCV and renal pathology requires further investigation.

Conclusions:

  • The management of patients with concurrent HCV infection and renal disease lacks robust guidelines.
  • Further well-designed studies are crucial to establish effective treatment protocols.
  • Understanding HCV's role in renal disease and vice versa is critical for improving patient outcomes.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
42
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
337
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
1.2K
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
354
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
630